EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer

Davide Illuminati iD, Rebecca Foschi, Paolo Marchetti iD, Vinicio Zanirato iD, Anna Fantinati iD, Claudio Trapella iD, Rebecca Voltan iD, Virginia Cristofori iD

Molecules · 2025

DOI: 10.3390/molecules30193908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Davide Illuminati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 213/d, 41125 Modena, Italy. Hauptthemen laut MEDLINE: Imidazoles, Piperazines, Antineoplastic Agents, Dichloroacetic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Claudio Trapella, National Recovery and Resilience Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric compounds represent a promising strategy in cancer therapy by simultaneously targeting multiple pathways responsible for tumour growth and survival. Their structure comprises two or more pharmacophores connected through suitable chemical linker. These dual or multi-functional drugs can interact with several biological targets for a more pronounced pharmacological effect. In order to identify new multi-targeting agents with anticancer efficacy, we designed and synthesised a series of novel multi-functional molecules by covalently linking antitumor compounds dichloroacetate (DCA) and Nutlin-3a. The design was aimed at addressing two critical events in cancer: (1) the Warburg effect and (2) the dysregulations of protein p53 pathway, both of which are directly linked to the predominant survival and aggressive proliferation of malignant cells. DCA reactivate oxidative phosphorylation by inhibiting mitochondria pyruvate dehydrogenase kinase (PDK), thereby unlocking the Warburg metabolism of cancer cells and its antiapoptosis state. Concurrently, Nutlin-3a restores the protective function of the “genome guardian” p53 protein, by blocking its antagonist oncoprotein E3 ligase MDM2. Chimeric compounds were obtained using a chemoenzymatic multi-step procedure that included a key lipase-catalysed asymmetric reaction. Biological evaluation of the synthesised Nutlin-DCA chimeras in a panel of three cancer cell lines demonstrated promising results in vitro. Specifically, compounds rac-19a, rac-19b, rac-20a, rac-20b and enantioenriched 20a caused a statistically significant reduction in cell viability at micromolar concentrations. These findings suggest that targeting both the Warburg effect and the p53 pathway with a single molecule is a viable approach for future cancer therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImidazolesPiperazinesAntineoplastic AgentsDichloroacetic AcidNeoplasmsHumansCell Line, TumorTumor Suppressor Protein p53ApoptosisCell ProliferationSignal TransductionProto-Oncogene Proteins c-mdm2Warburg Effect, OncologicCell SurvivalPyruvate Dehydrogenase Acetyl-Transferring KinaseOxidative Phosphorylation

Stichwörter der Autor:innen

DCANutlincancer researchchemoenzymatic synthesischimeric compounds

Substanzen

ImidazolesPiperazinesnutlin 3Antineoplastic AgentsDichloroacetic AcidTumor Suppressor Protein p53Proto-Oncogene Proteins c-mdm2Pyruvate Dehydrogenase Acetyl-Transferring Kinase

Autor:innen und Institutionen

  • Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 213/d, 41125 Modena, Italy.
  • Department of Environmental and Prevention Sciences, University of Ferrara, Via Luigi Borsari, 46, 44121 Ferrara, Italy.
  • Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Fossato di Mortara, 17, 44121 Ferrara, Italy.
  • Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), Via Fossato di Mortara, 70, 44121 Ferrara, Italy.

ORCID-Profile: Davide Illuminati, Paolo Marchetti, Vinicio Zanirato, Anna Fantinati, Claudio Trapella, Rebecca Voltan, Virginia Cristofori

Förderung

  • Claudio Trapella
  • National Recovery and Resilience Plan

Zitieren

APA

Illuminati, D., Foschi, R., Marchetti, P., Zanirato, V., Fantinati, A., Trapella, C., Voltan, R., & Cristofori, V. (2025). Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer. Molecules. https://doi.org/10.3390/molecules30193908

Vancouver

Illuminati D, Foschi R, Marchetti P, Zanirato V, Fantinati A, Trapella C, et al. Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer. Molecules. 2025. doi:10.3390/molecules30193908

BibTeX
@article{Illuminati2025,
  author = {Illuminati, Davide and Foschi, Rebecca and Marchetti, Paolo and Zanirato, Vinicio and Fantinati, Anna and Trapella, Claudio and Voltan, Rebecca and Cristofori, Virginia},
  title = {Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30193908}
}
Kostenlos starten →